🔎 Trials Near Me

Akèy › Lupus › Illinois › Chicago

Etid klinik pou Lupus nan Chicago, IL

8 etid pou Lupus ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

Ap rekriteFaz 3
  • Research Site, Chicago
  • Research Site, Chicago
Laj 5 a 17 · Tout sèks · Mizajou Sep 30, 2026 · NCT05835310

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

Ap rekriteFaz 2
  • University of Chicago, Chicago
Laj 16 a 70 · Tout sèks · Mizajou Sep 17, 2026 · NCT07328581

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • The University of Chicago Medical Center, Chicago
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Ap rekriteFaz 1/2
  • Research Site, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Ap rekriteFaz 3
  • Sl0044 50699, Chicago
Laj 16 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06617325

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Ap rekriteFaz 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Ap rekriteFaz 1/2
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

Lupus Landmark Study: A Prospective Registry and Biorepository

Ap rekriteEtid obsèvasyon
  • University of Chicago, Chicago
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Etid Lupus nan lòt vil

Lòt etid nan Chicago

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.